Suanfarma Suanfarma

X

Ethyl 4 - (1-Hydroxy -1 - Methyl Ethyl ) -2-Propyl-Imidazole-5-Carboxylate manufacturers and suppliers on PharmaCompass

PharmaCompass
Ethyl 4 - (1-Hydroxy -1 - Methyl Ethyl ) -2-Propyl-Imidazole-5-Carboxylate
Also known as: Akos033662426, Zinc225696306, Z1913691094, 1808823-02-0
Molecular Formula
C16H15N3O3S
Molecular Weight
329.4  g/mol
InChI Key
KABJBCXRECTLLG-UHFFFAOYSA-N

1 2D Structure

Ethyl 4 - (1-Hydroxy -1 - Methyl Ethyl ) -2-Propyl-Imidazole-5-Carboxylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(3-aminopyrazin-2-yl)sulfanylmethyl]-6-ethyl-7-hydroxychromen-2-one
2.1.2 InChI
InChI=1S/C16H15N3O3S/c1-2-9-5-11-10(6-14(21)22-13(11)7-12(9)20)8-23-16-15(17)18-3-4-19-16/h3-7,20H,2,8H2,1H3,(H2,17,18)
2.1.3 InChI Key
KABJBCXRECTLLG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC1=CC2=C(C=C1O)OC(=O)C=C2CSC3=NC=CN=C3N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Akos033662426

2. Zinc225696306

3. Z1913691094

4. 1808823-02-0

2.3 Create Date
2015-12-11
3 Chemical and Physical Properties
Molecular Weight 329.4 g/mol
Molecular Formula C16H15N3O3S
XLogP31.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass329.08341252 g/mol
Monoisotopic Mass329.08341252 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count23
Formal Charge0
Complexity474
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
144689-93-0
Olmesartan Medoxomil
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

INS 2024

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY